pancreatic ductal adenocarcinoma

Open Access
Contribution of Immunoscore to Survival Prediction in Pancreatic Ductal Adenocarcinoma
HARUKI MORI, TORU MIYAKE, HIROMITSU MAEHIRA, MASANORI SHIOHARA, HIROYA IIDA, NOBUHITO NITTA and MASAJI TANI

Anticancer Research October 2024, 44 (10) 4483-4492; DOI: https://doi.org/10.21873/anticanres.17277
You have access
A Comparative Analysis of ARX and ANFIS Models for Tumor Growth Prediction Under Single and Multi-agent Chemotherapy
SOTIRIOS G. LILIOPOULOS, GEORGE S. STAVRAKAKIS and KONSTANTINOS S. DIMAS

Anticancer Research June 2024, 44 (6) 2425-2436; DOI: https://doi.org/10.21873/anticanres.17049
You have access
Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma
HIROKI NAGARO, HIROSHI ICHIKAWA, KAZUYASU TAKIZAWA, MASAYUKI NAGAHASHI, SHUN ABE, YUKI HIROSE, KAZUKI MORO, KOHEI MIURA, MASATO NAKANO, YOSHIFUMI SHIMADA, JUN SAKATA and TOSHIFUMI WAKAI

Anticancer Research September 2023, 43 (9) 3969-3977; DOI: https://doi.org/10.21873/anticanres.16584
Open Access
Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells
DAISUKE TATSUDA, JUNJIRO YOSHIDA, TOMOKAZU OHISHI and MANABU KAWADA

Anticancer Research June 2023, 43 (6) 2477-2489; DOI: https://doi.org/10.21873/anticanres.16415
Open Access
Prophylactic Anticoagulation in Patients With Pancreatic Adenocarcinoma: A Single Tertiary Care Center Retrospective QI Project
SHIVANI SHAH, CHELSEA PETERSON, JIAXIANG LIU and DULABH K. MONGA

Anticancer Research January 2023, 43 (1) 137-141; DOI: https://doi.org/10.21873/anticanres.16142
Open Access
D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study
TARO SAKAMOTO, TAKESHI GOCHO, MASASHI TSUNEMATSU, YOSHIHIRO SHIRAI, RYOGA HAMURA, KOICHIRO HARUKI, KYOHEI ABE, TOMOYOSHI OKAMOTO, HIRONORI SHIOZAKI, SHUICHI FUJIOKA, RYOTA IWASE, YU KUMAGAI, TERUYUKI USUBA and TORU IKEGAMI

Anticancer Research January 2023, 43 (1) 201-208; DOI: https://doi.org/10.21873/anticanres.16150
You have access
Intracellular C3 Modulates EMT via the Akt/Smad Pathway in Pancreatic Cancer Cells
REI SUZUKI, TADAYUKI TAKAGI, MITSURU SUGIMOTO, YUKI SATO, HIROKI IRIE, YUKI YOMOGIDA and HIROMASA OHIRA

Anticancer Research December 2022, 42 (12) 5743-5750; DOI: https://doi.org/10.21873/anticanres.16081
You have access
Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
YOSHIKI NAITO, JUN AKIBA, YOSHINAO KINJO, EIJI SADASHIMA, TOSHIRO OGATA, YUTA YANO, MASAHIKO TANIGAWA, MASAMICHI NAKAYAMA, AKIHIKO KAWAHARA, YOSHINOBU OKABE, HISAMUNE SAKAI, TORU HISAKA, YOSHITO AKAGI and HIROHISA YANO

Anticancer Research August 2022, 42 (8) 4145-4151; DOI: https://doi.org/10.21873/anticanres.15913
Open Access
The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC)
SKAISTE TULYTE, DAINIUS CHARACIEJUS, REDA MATUZEVICIENE, AUSRA JANIULIONIENE, MANTAS RADZEVICIUS, TADAS ZVIRBLIS and AUDRIUS SILEIKIS

Anticancer Research June 2022, 42 (6) 3067-3073; DOI: https://doi.org/10.21873/anticanres.15794
You have access
Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
HAJIME MATSUSHIMA, TOMOHIKO ADACHI, MASAAKI HIDAKA, MAMPEI YAMASHITA, TAKASHI HAMADA, SAEKO FUKUI, TAKAYUKI TANAKA, HAJIME IMAMURA, KYOHEI YOSHINO, TOTA KUGIYAMA, AMANE KITASATO, TAKANOBU HARA, AKIHIKO SOYAMA, KAZUMA KOBAYASHI, YORIHISA SUMIDA, TAMOTSU KUROKI and SUSUMU EGUCHI

Anticancer Research June 2022, 42 (6) 3133-3141; DOI: https://doi.org/10.21873/anticanres.15802

Main menu

User menu

Search

pancreatic ductal adenocarcinoma

Pages